loader
Please Wait
Applying Filters...

Latest U.S. Prescription Data for Drugs containing pentyl N-[1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-methyloxolan-2-yl]-5-fluoro-2-oxopyrimidin-4-yl]carbamate under Medicare's Part D Prescription Drug Program. Original Data: Centers for Medicare & Medicaid Services Website

Menu
$ API Ref.Price (USD/KG) : 241Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1CAPECITABINE

02 5Capecitabine

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass
Left Arrow
Right Arrow

01

arrow
The Battery Show
Not Confirmed
arrow
The Battery Show
Not Confirmed

Company :

Capecitabine

Drug Cost (USD) : 44,658

Year : 2022

Prescribers : 75

Prescriptions : 276

blank

02

arrow
The Battery Show
Not Confirmed
arrow
The Battery Show
Not Confirmed

Company :

Capecitabine

Drug Cost (USD) : 28,361

Year : 2022

Prescribers :

Prescriptions : 21

blank

03

arrow
The Battery Show
Not Confirmed
arrow
The Battery Show
Not Confirmed

Company :

Capecitabine

Drug Cost (USD) : 137,580

Year : 2021

Prescribers : 91

Prescriptions : 312

blank

04

arrow
The Battery Show
Not Confirmed
arrow
The Battery Show
Not Confirmed

Company :

Capecitabine

Drug Cost (USD) : 7,690

Year : 2021

Prescribers :

Prescriptions : 13

blank

05

arrow
The Battery Show
Not Confirmed
arrow
The Battery Show
Not Confirmed

Company :

Capecitabine

Drug Cost (USD) : 93,612

Year : 2020

Prescribers : 63

Prescriptions : 206

blank

06

arrow
The Battery Show
Not Confirmed
arrow
The Battery Show
Not Confirmed

Company :

CAPECITABINE

Drug Cost (USD) : 49,069

Year : 2014

Prescribers :

Prescriptions : 17

blank